Comparing Approaches to Treat Older Adult Women's Urge Incontinence: Pilot Feasibility and Randomized Controlled Trial (SHUW)
Comparing Mindfulness-Based Stress Reduction With the Health Enhancement Program in the Treatment of Urinary Urge Incontinence in Older Adult Women: A Pilot Feasibility and Randomized Controlled Trial
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
The overarching goal of this research is to evaluate potential treatment options for older women with symptoms of urinary urge incontinence, with a specific focus on Mindfulness-Based Stress Reduction, a promising therapeutic approach in preliminary studies and one increasingly used to treat symptoms associated with brain-visceral interactions. Feasibility and preliminary efficacy will be tested in two randomized study arms: a Mindfulness-Based Stress Reduction intervention group and a Health Enhancement Program intervention comparison group.
This research study will explore the feasibility and preliminary efficacy of treating urinary urge incontinence in older adult women with mindfulness-based stress reduction in comparison to the health enhancement program through a randomized controlled pilot study. Feasibility determinants will include both research feasibility (recruitment, retention, treatment fidelity) and intervention feasibility (acceptability, tolerability, treatment adherence). Clinical outcomes to evaluate preliminary intervention efficacy will include severity of urinary urge incontinence symptoms, bother of urinary urge incontinence symptoms, perceived stress, and perceived level of self-efficacy of self-management of urinary urge incontinence symptoms. Preliminary efficacy of the intervention will also be evaluated with the Patient Global Impression of Improvement, a process measure that rates the patient's "response of a condition to a therapy" (Ryan, n.d., p. 1).
This combined pilot feasibility study and randomized controlled trial will evaluate specific factors crucial to the success of a large trial to evaluate the effect of Mindfulness-Based Stress Reduction on urinary urge incontinence in older adult women. Moore (2011) recommended that the pilot study design parallel the future larger study, particularly when evaluating feasibility in the pilot study. The capacity for hypothesis testing, or establishing causal inference is limited in a pilot study due to insufficient power; however, the information from efficacy testing is vital in informing future larger scale clinical trials. This study will serve as a necessary step for the development of effectiveness trials of Mindfulness-Based Stress Reduction in treatment of urinary urge incontinence in older adult women by informing and guiding evaluation, implementation, and dissemination.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Utah
-
Salt Lake City, Utah, Forenede Stater, 84112
- University of Utah
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
The following eligibility criteria must be met for the potential participant to be considered for enrollment.
- The study is enrolling older adult women, with urinary urge incontinence.
- They cannot be currently treating their urinary urge incontinence with medication as this will confound results.
- Women who have attempted more extreme treatments and are still experiencing urinary urge incontinence will not be considered as potential participants, as it is unlikely that mindfulness-based stress reduction would treat urinary urge incontinence that is refractory to that degree.
- Participants must be English speaking, as the interventions and homework will be delivered in English.
- postmenopausal women
- Urge predominant urinary incontinence, defined as score of ≥ 3 (moderate to severe urinary incontinence) on the Incontinence Severity Index
- Urge predominant urinary incontinence as determined by question 3 on the 3 Incontinence Questions. The 3 Incontinence Questions has been shown to be a quick and accurate way of diagnosing stress, urge or mixed incontinence in most cases
- Has experienced urinary urge incontinence symptoms for at least three months
- Committed to attend 8 weekly sessions and one half day retreat between weeks 6 and 7
- No pharmacologic therapy for urinary urge incontinence within three weeks of enrollment and no plan to initiate such medications during the 8 week active treatment
- If on hormone therapy or vaginal estrogen, plan to remain on it for the duration of the study; if not on it, no plan to initiate
- No previous intradetrusor Botox injection for urinary urge incontinence and no plan to receive it during the intervention
- No previous neurostimulation for urinary urge incontinence and no plan to receive it during the intervention English speaking
- A score of >24 on the Montreal Cognitive Assessment
Exclusion Criteria:
The following exclusions are applied, as they could seriously limit participation or confound participant response to the intervention:
- Predominantly stress, mixed, or other type of incontinence as determined by question 3 on the 3 Incontinence Questions
- Currently taking medications for Alzheimer's disease or other dementias; these medications could interfere with their participation
- Known neurologic disease acknowledged to impact bladder function including Parkinson's disease, spinal cord injury, or stroke affecting urinary control; these diseases provide cause for urinary urge incontinence and as such the participant would be unlikely to benefit from the intervention
- Current symptomatic urinary tract infection that has not resolved prior to the start of intervention
- Current bladder infection that has not resolved prior to the start of intervention
- Use of an assistive device for ambulation (such as a cane, walker, or wheelchair) and feels that difficulties with bladder management are related to the slowed time in visiting the restroom ("Was urinary urge incontinence a problem before you began using the assistive device?")
- Functionally incontinent, in other words, having a mental or physical condition that prevents a person from visiting the restroom in time
- Ever diagnosed with interstitial cystitis
- Self-report of vaginal bulge protruding outside of the vagina
- Past participation in a formal program of mindfulness-based stress reduction
- Substantial, uncorrected hearing loss
- Substantial, uncorrected vision loss
- Limitations that preclude completing study questionnaires or surveys, such as difficulties with reading and writing or a cognitive impairment
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Mindfulness-Based Stress Reduction
8 week manualized, standardized mindfulness-based stress reduction program taught by a certified Mindfulness-Based Stress Reduction instructor
|
This experimental arm presents the actual Mindfulness-Based Stress Reduction program as developed in the late seventies and early eighties in its original eight week format
|
|
Aktiv komparator: Health Enhancement Program
8 week manualized, standardized health enhancement program, taught by a certified health education specialist
|
This active comparison arm presents the official Health Enhancement Program in its eight week format as developed by MacCoon in 2009.
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of potential participants contacted
Tidsramme: 10 weeks
|
number of people who contacted PI during recruitment process, including the place they heard about the study
|
10 weeks
|
|
number of enrolled participants completing the study
Tidsramme: 12 weeks
|
number of participants who attended at least five of nine classes number of excused absences number of unexcused absences
|
12 weeks
|
|
percentage of course content delivered during intervention
Tidsramme: 44 weeks
|
weekly interventionist report on what was taught participants perception of course content delivered measured by a checklist of concepts covered in the weekly interventions at study completion
|
44 weeks
|
|
positive or negative coded responses to the question "How did it go today?"
Tidsramme: 8 weeks
|
data coded from two participants' responses after each class in each arm
|
8 weeks
|
|
number of participants who completed each week's homework practice
Tidsramme: 8 weeks
|
participants mark on homework practice log and submit weekly
|
8 weeks
|
|
number of participants recruited for enrollment
Tidsramme: 10 weeks
|
potential participants who were interested in the study
|
10 weeks
|
|
number of potential participants who are eligible to enroll
Tidsramme: 10 weeks
|
number of people who passed the screening process via calls or emails
|
10 weeks
|
|
consent rate
Tidsramme: 10 weeks
|
number of participants who are willing to sign consent document at enrollment interview; number who pass the Montreal Cognitive Assessment and are willing to sign consent document
|
10 weeks
|
|
number of participants enrolled
Tidsramme: 10 weeks
|
number of people who enrolled into the study
|
10 weeks
|
|
number of dropouts due to stated distress from or dislike of either intervention experience (as opposed to someone needing to withdraw due to a family emergency or illness)
Tidsramme: 8 weeks
|
participant self-report of what made the intervention challenging - why they were unable or unwilling to complete the course
|
8 weeks
|
|
- number of minutes of homework practice each week
Tidsramme: 8 weeks
|
totaled from daily numbers reported by participant
|
8 weeks
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
change in symptom severity
Tidsramme: 16 weeks, 6 months
|
measured by the Incontinence Severity Index
|
16 weeks, 6 months
|
|
change in symptom bother
Tidsramme: 16 weeks, 6 months
|
measured by the Overactive Bladder questionnaire, short form
|
16 weeks, 6 months
|
|
change in perceived stress
Tidsramme: 16 weeks, 6 months
|
measured by the Perceived Stress Scale
|
16 weeks, 6 months
|
|
change in perceived self-efficacy
Tidsramme: 16 weeks, 6 months
|
measured by the Geriatric Self Efficacy Index for Urinary Incontinence
|
16 weeks, 6 months
|
|
self report of rate and trajectory of change in participant impression of improvement
Tidsramme: 16 weeks, 6 months
|
measured by the Patient Global Impression of Improvement
|
16 weeks, 6 months
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Ledende efterforsker: Katarina F Felsted, MS, University of Utah
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 00095461
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Urininkontinens, Urge
-
NCT04232696Aktiv, ikke rekrutterendeUrinary Urgency Inkontinens
-
NCT01843543AfsluttetUrinary Urgency Inkontinens
-
NCT07569822Ikke rekrutterer endnu
-
NCT07144813RekrutteringUrinary Urgency Inkontinens
-
NCT02130518UkendtUrinary Catheter Blokering og Encrustation
-
NCT01807260AfsluttetPædiatrisk Urinary Lithiasis
-
NCT01243125AfsluttetUrinary Catheter Blokering og Encrustation
-
NCT00826527UkendtNocturia | Urinary Urgency | Urinhyppighed
-
NCT02598726AfsluttetSmerte | Ondartet neoplasma | Urinary Urgency | Blære Spasmer
-
NCT01589484AfsluttetNyre Calculi | Urolithiasis | Urinary Lithiasis
Kliniske forsøg med Mindfulness-Based Stress Reduction
-
NCT01367639AfsluttetArvelig bryst- og ovariecancersyndrom
-
NCT03162276UkendtArvelig bryst- og ovariecancersyndrom
-
NCT04392869AfsluttetAngst | Psykisk nød | Perfektionisme | Opmærksomhed | Empati | Kreativitet | Livsstress | Følelsesmæssig intelligens